Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Balanced Randomised Placebo Controlled Double-blind Phase IIa Study to Investigate the Efficacy and Safety of AUT00063 Versus Placebo in Subjective Tinnitus

NCT02315508 is registered in ClinicalTrials.gov with Autifony Therapeutics Limited as lead sponsor.

NCT NCT02315508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02315508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Balanced Randomised Placebo Controlled Double-blind Phase IIa Study to Investigate the Efficacy and Safety of AUT00063 Versus Placebo in Subjective Tinnitus
Lead sponsor
Autifony Therapeutics Limited
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2014
Completion date
December 31, 2015
Enrollment
91 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

tinnitus, subjective